Curie.Bio, the biotech accelerator and investment firm, has raised another $340 million to invest in startups.

Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...

The Curio Bioscience acquisition will extend the power of Takara Bio’s NGS solutions and give customers deeper insights into tissue spatial organization and molecular composition. “We are ...

Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery. Inventia Life Science, an innovator in ...

By Douglas G. Tiffany, an energy economist, University of Minnesota Extension Twenty-one billion gallons of second-generation biofuels made from non-grain feedstocks must enter the nation’s ...

Mark joins Kincell Bio with a wealth of experience in the biopharmaceutical industry, having founded and served as CEO of three successful Contract Development and Manufacturing Organizations ...